Oslo Cancer Cluster is a research- and industrial member organization that gathers players from the entire oncology value chain, creating a network of biotech industry partners, pharmaceutical companies, investors, academic research institutions, universities, university hospitals and unions.
At present (2017) the cluster comprises almost 90 network members from Norway and Northern Europe. Together they work to fulfill Oslo Cancer Cluster’s vision of accelerating the development of new cancer treatments. Activities also include advocacy to improve terms and conditions for biotech and oncology start-ups.
Oslo Cancer Cluster is an essential instrument for RADFORSK to execute its vision: to accelerate commercialization of cancer and oncology research.
The Oslo Cancer Cluster Incubator is an integrated part of the Oslo Cancer Cluster Innovation Park and supports promising oncology biotech start-ups to commercialise successfully. The Incubator provides a dynamic, creative and professional growth environment for scientists & start-ups.
The Incubator is an essential instrument for Oslo Cancer Cluster and RADFORSK in bringing a variety of oncology industry players – from investors to start-ups – together. The OCC Incubator creates synergies across disciplines.
Oslo Cancer Cluster Incubator AS opened in 2015 and is partly owned by RADFORSK.
The vision of the Oslo Cancer Cluster Innovation Park is to create Europe’s leading environment for education, research and industry within oncology, while shortening the time it takes to develop new cancer medication and diagnostics.
The 36 000 m² Innovation Park opened in September 2015. Located next to the Norwegian Radium Hospital and the Institute for Cancer Research at Oslo University Hospital, The Innovation Park – comprising the Oslo Cancer Cluster, Ullern High School and Oslo Cancer Cluster Incubator – co-locates education, research and industry at a joint innovation campus in Oslo. The Innovation Park thus creates synergies across the entire oncology-value chain.